A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and medical research charity Lifearc have announced a collaboration to develop an affordable and accessible monoclonal ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in ...

Representative Vern Buchanan (R-FL) issued a statement praising the Food and Drug Administration's (FDA) recent decision to ...

HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has ...

Despite its vital role in "kick-starting" the immune response, IgD is arguably the least understood antibody, with little known about how it might participate in other parts of the immune system. A ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...